120 related articles for article (PubMed ID: 38327236)
1. A disulfide molecule-vancomycin nanodrug delivery system efficiently eradicates intracellular bacteria.
Luo Y; Su L; Yang H; Geng A; Bai S; Zhou J
J Mater Chem B; 2024 Feb; 12(9):2334-2345. PubMed ID: 38327236
[TBL] [Abstract][Full Text] [Related]
2. Potent antibacterial nanoparticles for pathogenic bacteria.
Lai HZ; Chen WY; Wu CY; Chen YC
ACS Appl Mater Interfaces; 2015 Jan; 7(3):2046-54. PubMed ID: 25584802
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of vancomycin-functionalized ZnFe
Akbari M; Rezayan AH; Rastegar H; Alebouyeh M; Yahyaei M
Drug Dev Res; 2024 Feb; 85(1):e22148. PubMed ID: 38349268
[TBL] [Abstract][Full Text] [Related]
4. Dual-targeted poly(amino acid) nanoparticles deliver drug combinations on-site: an intracellular synergistic strategy to eliminate intracellular bacteria.
Zhao D; Feng W; Kang X; Li H; Liu F; Zheng W; Li G; Wang X
J Mater Chem B; 2023 Mar; 11(13):2958-2971. PubMed ID: 36919349
[TBL] [Abstract][Full Text] [Related]
5. Conformationally restricted, dipeptide-based, self-assembled nanoparticles for efficient vancomycin delivery.
Yadav N; Kumar U; Chauhan VS
Nanomedicine (Lond); 2022 Nov; 17(26):2023-2035. PubMed ID: 36645108
[TBL] [Abstract][Full Text] [Related]
6. Osteogenic and anti-inflammatory potential of oligochitosan nanoparticles in treating osteomyelitis.
Zhang S; Chen G; Wang M; Lin B; Gao X; Hu J; Chen B; Zhang C
Mater Sci Eng C Mater Biol Appl; 2022 Apr; 135():112681. PubMed ID: 35589470
[TBL] [Abstract][Full Text] [Related]
7. pH-Responsive Lipid-Dendrimer Hybrid Nanoparticles: An Approach To Target and Eliminate Intracellular Pathogens.
Maji R; Omolo CA; Agrawal N; Maduray K; Hassan D; Mokhtar C; Mackhraj I; Govender T
Mol Pharm; 2019 Nov; 16(11):4594-4609. PubMed ID: 31593478
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial and biofilm-inhibitory effects of vancomycin-loaded mesoporous silica nanoparticles on methicillin-resistant staphylococcus aureus and gram-negative bacteria.
Memar MY; Yekani M; Farajnia S; Ghadiri Moghaddam F; Nabizadeh E; Sharifi S; Maleki Dizaj S
Arch Microbiol; 2023 Mar; 205(4):109. PubMed ID: 36884153
[TBL] [Abstract][Full Text] [Related]
9. Synergetic effect of vancomycin loaded silver nanoparticles for enhanced antibacterial activity.
Kaur A; Preet S; Kumar V; Kumar R; Kumar R
Colloids Surf B Biointerfaces; 2019 Apr; 176():62-69. PubMed ID: 30594704
[TBL] [Abstract][Full Text] [Related]
10. GSH/pH Cascade-Responsive Nanoparticles Eliminate Methicillin-Resistant
Kang X; Yang X; Bu F; Feng W; Liu F; Xie W; Li G; Wang X
ACS Appl Mater Interfaces; 2024 Jan; 16(3):3202-3214. PubMed ID: 38207171
[TBL] [Abstract][Full Text] [Related]
11. NIR-Ⅱ window Triple-mode antibacterial Nanoplatform: Cationic Copper sulfide nanoparticles combined vancomycin for synergistic bacteria eradication.
Li C; Gao F; Tong Y; Chang F; Han H; Liu C; Xu M; Li H; Zhou J; Li X; Wang F; Jiang Y
J Colloid Interface Sci; 2022 Dec; 628(Pt B):595-604. PubMed ID: 36027770
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin modified copper sulfide nanoparticles for photokilling of vancomycin-resistant enterococci bacteria.
Zou Z; Sun J; Li Q; Pu Y; Liu J; Sun R; Wang L; Jiang T
Colloids Surf B Biointerfaces; 2020 May; 189():110875. PubMed ID: 32087532
[TBL] [Abstract][Full Text] [Related]
13. Effect of ZnO nanoparticles on methicillin, vancomycin, linezolid resistance and biofilm formation in Staphylococcus aureus isolates.
Abdelraheem WM; Khairy RMM; Zaki AI; Zaki SH
Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):54. PubMed ID: 34419054
[TBL] [Abstract][Full Text] [Related]
14. Engineering of a Dual-Recognition Ratiometric Fluorescent Nanosensor with a Remarkably Large Stokes Shift for Accurate Tracking of Pathogenic Bacteria at the Single-Cell Level.
Shen Y; Wu T; Zhang Y; Ling N; Zheng L; Zhang SL; Sun Y; Wang X; Ye Y
Anal Chem; 2020 Oct; 92(19):13396-13404. PubMed ID: 32867467
[TBL] [Abstract][Full Text] [Related]
15. Liquid crystalline lipid nanoparticles improve the antibacterial activity of tobramycin and vancomycin against intracellular Pseudomonas aeruginosa and Staphylococcus aureus.
Subramaniam S; Joyce P; Prestidge CA
Int J Pharm; 2023 May; 639():122927. PubMed ID: 37059243
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin as an Antibacterial Agent Capped with Silver Nanoparticles: An Experimental Potential Analysis.
Patwekar M; Patwekar F; Alghamdi S; Kamal M; Allahyani M; Almehmadi M; Kabrah A; Dablool AS; Alsaiari AA; Jawaid T; Medikeri A; Samuel K; Islam F
Biomed Res Int; 2022; 2022():3682757. PubMed ID: 36046462
[TBL] [Abstract][Full Text] [Related]
17. Efficient induction of antimicrobial activity with vancomycin nanoparticle-loaded poly(trimethylene carbonate) localized drug delivery system.
Zhang Y; Liang RJ; Xu JJ; Shen LF; Gao JQ; Wang XP; Wang NN; Shou D; Hu Y
Int J Nanomedicine; 2017; 12():1201-1214. PubMed ID: 28243084
[TBL] [Abstract][Full Text] [Related]
18. A macrophage cell membrane-coated cascade-targeting photothermal nanosystem for combating intracellular bacterial infections.
Xiong J; Tang H; Sun L; Zhu J; Tao S; Luo J; Li J; Li J; Wu H; Yang J
Acta Biomater; 2024 Feb; 175():293-306. PubMed ID: 38159895
[TBL] [Abstract][Full Text] [Related]
19. Vancomycin-modified mesoporous silica nanoparticles for selective recognition and killing of pathogenic gram-positive bacteria over macrophage-like cells.
Qi G; Li L; Yu F; Wang H
ACS Appl Mater Interfaces; 2013 Nov; 5(21):10874-81. PubMed ID: 24131516
[TBL] [Abstract][Full Text] [Related]
20. Intracellular infection-responsive macrophage-targeted nanoparticles for synergistic antibiotic immunotherapy of bacterial infection.
Dai X; Li Y; Liu X; Zhang Y; Gao F
J Mater Chem B; 2024 May; 12(21):5248-5260. PubMed ID: 38712662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
